Drug services professional

Around half of current injecting drug users will have hepatitis C, although this prevalence rate varies across the country.  Find here tools, resources and other relevant documents to help drugs service staff raise awareness of hepatitis C amongst service users, and improve testing and access to care.

Showing 161 to 170 of 248 resources

  • HCV Action good practice film: Community-based treatment in Lambeth
    In this good practice film, HCV Action interview Katherine Oakes, Senior Nurse for Viral Hepatitis at Kings College Hospital, and Dee Cunniffe, Policy Lead and Project Manager at the London Joint Working Group on Substance Use and Hepatitis C. They talk about the outreach service established in Lambeth to provide specialist care to hepatitis C-infected substance users in the borough, which has a higher than average prevalence of hepatitis C among injecting drug users compared to London as a whole.
    UK, England, Greater London Feb 2015 Case study Video
  • Hepatitis C in London
    This Public Health England report focuses on the epidemiology of hepatitis C in London, and provides recommendations for stakeholders on measures to prevent further infections and reduce morbidity and mortality of those already infected with the virus.
    UK, England, Greater London Feb 2015 Reports & Research, Strategy & Planning PDF
  • HCV Action good practice film: Addaction workforce development programme
    In this good practice film, HCV Action interviews David Badcock of Addaction and Stuart Smith of The Hepatitis C Trust, about the development and implementation of an Addaction workforce development programme, which aimed to improve awareness and knowledge of hepatitis C among Addaction staff. The programme was formed as a result of a partnership between Addaction and The Hepatitis C Trust, and involved the secondment of Stuart Smith, National Drug Services Lead at The Hepatitis C Trust, to Addaction to develop and deliver training to Addaction staff.
    UK, England, Scotland, Wales, Greater London Jan 2015 Case study, Training Video
  • HCV Action good practice case study: Dorset BBV Dry Blood Spot Testing Service Pathway
    This written case-study looks at the Dorset Blood Borne Virus Dry Blood Spot Testing Service Pathway, a model of care and pathway devised through joint working between primary and secondary care, which primarily involves the implementation of DBST hepatitis C testing within drug services, including voluntary charitable organisations. It was introduced in Bournemouth in 2011 and has subsequently been rolled out across Dorset, with 90% of all people accessing drug treatment services in the area are now being tested for hepatitis C.
    UK, England, South West Dec 2014 Case study PDF
  • HCV Action good practice case study: HCV Management Model in Cornwall
    The hepatitis C management model that has been developed in recent years in Cornwall provides an integrated model of care for people with hepatitis C in the county, incorporating partnerships between hospital-based hepatology and drug and alcohol services and spanning testing, treatment and care.
    UK, England, South West Dec 2014 Case study PDF
  • Social Impact of HCV
    This presentation from Dr Rui Tato Marinho, Gastroenterologist at Lisbon Medical School, was first delivered at the 'HCV and Your Body' conference in Amsterdam in November 2014. It provides an overview of the physical, mental and social impact of hepatitis C, and covers issues such as stigma; homelessness; unemployment and loss of productivity.
    UK, Rest of World Nov 2014 Other, Reports & Research PDF
  • Practical steps to eliminating hepatitis C: A consensus for London
    The London Joint Working Group on Substance Use and Hepatitis C (LJWG) have updated their 2011 London Consensus to make it relevant to the NHS in London today, in the era of new treatments and opportunities.
    UK, England, Greater London Nov 2014 Reports & Research PDF
  • HCV Action good practice case study: Widening access to treatment for PWIDs in Tayside
    This HCV Action good practice case study looks at the Tayside Hepatitis C Managed Care Network (MCN), and its work in making testing and treatment as accessible as possible to people who inject drugs. Established in 2004, the MCN has introduced a number of highly effective facets to its referral and treatment pathway, including the use of non-medical referrals, outreach clinics, and the roll-out of dry blood spot testing in non-clinical settings. It acts as an excellent example of how to respond to the particular needs of cohorts who can often find it difficult to access services.
    UK, Scotland Nov 2014 Case study PDF
  • Shooting up Infections among people who inject drugs in the United Kingdom 2013: An update November 2014
    A Public Health England update on the 2013 report, highlighting that hepatitis C levels are still high; that hepatitis B is now rare and vaccine uptake has improved; that HIV levels remain low and the uptake of care is good; that bacterial infections remain a major problem; that injecting risk behaviours have declined but remain a problem; and that changing patterns of psychoactive drug injection are a cause for concern. The report recommends that the provision of effective interventions need to be maintained.
    England Nov 2014 Reports & Research PDF
  • Database: Secondary care prison hospital contacts for hepatitis C treatment
    This database lists the hospital contact details of secondary care lead consultants and lead nurses in England responsible for hepatitis C treatment. The database lists the detention centre to which each hospital is connected, the hospital providing treatment, and the lead consultant and lead nurse's name, email address and telephone number. It is aimed at supporting the roll-out of opt-out blood-borne virus testing currently being implemented in prisons across England.
    England 2014 Tools & Templates MS Excel